Erythropoietin Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Erythropoietin stocks.

Erythropoietin Stocks Recent News

Date Stock Title
Nov 2 TECH Batman Fan? You Can Now Score A Full Size Batmobile Replica For An Eye-Watering Price Of $3M
Nov 2 TECH This Is What OpenAI's Sam Altman Had To Say On The Future Of Open Source At ChatGPT-Parent
Nov 2 TECH Elon Musk Slams Immigration Rules After Perplexity CEO Reveals 3-Year Wait For Green Card: 'We Have An Upside Down System'
Nov 2 TECH Honda's Pickup Beats Tesla Cybertruck As Most American Made Truck
Nov 2 TECH Apple's iPhone 17 Base Models Could Finally Get This Highly Requested 'Pro' Feature
Nov 2 TECH Autonomous Vehicle Startup Aurora Pushes Back Commecial Launch Of Driverless Trucks To 2025
Nov 2 TECH Nvidia Rides AI Wave To Replace Intel On Dow Jones Industrial Average, Ending Its 25-Year Run
Nov 2 TECH Tesla Investor Says EV Giant Will 'Admit' It Needs Lidar Despite Elon Musk Calling It A Crutch
Nov 2 TECH Elon Musk's X Reportedly Hit With New Wave Of Layoffs: Engineering Department Faces Major Cuts Amid Uncertain Future
Nov 1 TECH Intel Struggles With Market Share, Profitability: Q3 Analyst Insights
Nov 1 TECH Intel Says It Won't Even Make $500M From Gaudi AI Chips In 2024 Despite Nvidia Minting Billions: CEO Gelsinger Says Uptake 'Slower Than We Anticipated'
Nov 1 TECH Apple, Microsoft Need To Do More Than Just Beating Wall Street Estimates, Says Analyst: 'AI Enthusiasm And Potential Is Not Enough"
Nov 1 TECH EV Truck Maker Nikola Yet To Return Many BEVs Recalled Last Year, Says CFO
Nov 1 TECH Jim Cramer Warns Apple Stock Should Have 'Never Been Up That Much' After Q3 Earnings Even As This Analyst Defends iPhone 16 Launch
Nov 1 TECH Marc Andreessen, Palmer Luckey Accuse YouTube Of 'Deliberate Censorship' As Trump-Rogan Episode Controversy Rages On: 'These Are Not Accidents'
Nov 1 TECH Ford F-150 Lightning Pickup Truck Production To Be Halted Temporarily After Tesla's Cybertruck Races Ahead In Q3
Nov 1 TECH Tim Cook Underscores 'Several Positive Signs' In Apple's China Performance, Refrains From Talking About Economic Stimulus: 'Don't Want To Ad-Lib On The Effect Of It'
Nov 1 TECH Tesla Can Make Cybercab For The Same Money It Takes Waymo To Install Lidar Sensors On Its Robotaxi, Says Ark Analyst
Nov 1 TECH Andy Jassy Touts 'Deep Partnership' With Nvidia, But Amazon Is Doubling Down On In-House Custom Silicon For Price-Conscious Customers
Nov 1 TECH Apple Users Hungry For AI: Tim Cook Says 'iOS 18.1 Has Twice The Adoption Rate Of 17.1' — What It Means For iPhone 16
Erythropoietin

Erythropoietin (; EPO), also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidney in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. Low levels of EPO (around 10 mU/mL) are constantly secreted sufficient to compensate for normal red blood cell turnover. Common causes of cellular hypoxia resulting in elevated levels of EPO (up to 10 000 mU/mL) include any anemia, and hypoxemia due to chronic lung disease.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. Liver production predominates in the fetal and perinatal period; renal production predominates in adulthood. It is homologous with thrombopoietin.
Exogenous erythropoietin, recombinant human erythropoietin (rhEPO), is produced by recombinant DNA technology in cell culture and are collectively called erythropoiesis-stimulating agents (ESA): two examples are epoetin alfa and epoetin beta. ESAs are used in the treatment of anemia in chronic kidney disease, anemia in myelodysplasia, and in anemia from cancer chemotherapy. Risks of therapy include death, myocardial infarction, stroke, venous thromboembolism, and tumor recurrence. Risk increases when EPO treatment raises hemoglobin levels over 11 g/dL to 12 g/dL: this is to be avoided.
rhEPO has been used illicitly as a performance-enhancing drug. It can often be detected in blood, due to slight differences from the endogenous protein; for example, in features of posttranslational modification.

Browse All Tags